Lack of association between rs3807989 in cav1 and atrial fibrillation

Guocao Li; Rongfeng Zhang; Lianjun Gao; Shulong Zhang; Yingxue Dong; Xiaomeng Yin; Dong Chang; Yanzong Yang; Yunlong Xia
July 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4339
Academic Journal
No abstract available.


Related Articles

  • About Atrial Fibrillation.  // Medical Update;2003, Vol. 28 Issue 11, p5 

    Provides information on atrial fibrillation. Difference between atrial fibrillation and ventricular fibrillation; Medications used to slow down rapid heart rate associated with atrial fibrillation; Details of a technique called radiofrequency ablation; Estimated number of U.S. citizens with...

  • The management of atrial fibrillation in elderly patients. Hampton, John R. // Age & Ageing;May99, Vol. 28 Issue 3, p248 

    Describes atrial fibrillation. Causes; Drug therapy for atrial fibrillation; Stroke association with atrial fibrillation.

  • Stroke prevention in nonvalvular atrial fibrillation. Albers, Gregory W.; Atwood, J. Edwin; Hirsch, Jack; Sherman, David G.; Hughes, Robert A.; Connolly, Stuart J.; Albers, G W; Atwood, J E; Hirsh, J; Sherman, D G; Hughes, R A; Connolly, S J // Annals of Internal Medicine;11/1/91, Vol. 115 Issue 9, p727 

    There has been considerable uncertainty about the best way to prevent stroke in patients with nonvalvular atrial fibrillation. Recent studies have suggested that low-dose warfarin therapy, in addition to producing fewer bleeding complications, may be as effective as higher-dose therapy in...

  • Atrial fibrillation risk: Choose your parents wisely.  // Primary Care Reports;Feb2011, Vol. 17 Issue 2, p3 

    The article discusses a study published in the "Journal of the American Medical Association" (JAMA) which examined the association between familial atrial fibrillation and risk of new-onset atrial fibrillation.

  • More evidence that warfarin is not being utilized enough.  // Modern Medicine;Mar97, Vol. 65 Issue 3, p19 

    Focuses on a study by Lawrence M. Brass touting increased utilization of warfarin sodium in elderly patients with atrial fibrillation. Evidence that the anticoagulant lowers the risk of stroke; Association between atrial fibrillation and strokes in patients aged 80 and older.

  • A preventable cause of stroke. Lipman, Marvin M. // Consumer Reports on Health;Sep2010, Vol. 22 Issue 9, p11 

    The article discusses the relationship between atrial fibrillation and stroke. A discussion of the causes and physiology of atrial fibrillation is presented. Common treatments, including a blood thinner called warfarin, that are used in the treatment of atrial fibrillation, are discussed. Side...

  • Rate vs. Rhythm Control for Atrial Fibrillation. Miller, Karl E. // American Family Physician;6/1/2005, Vol. 71 Issue 11, p2192 

    Discusses research being done on rate control in patients with nonvalvular persistent atrial fibrillation. Reference to a study by G. Opolski and associates, published in the August 2004 issue of the "Chest"; Effect of the rhythm method on nonvalvular atrial fibrillation; Methodology used;...

  • Physical Activity and the Risk of Atrial Fibrillation. DiMarco, John P. // Clinical Cardiology Alert;Oct2008, Vol. 27 Issue 10, p90 

    The article discusses a research on physical activity and incidence of atrial fibrillation in older adults. Results of the study showed an association between increased leisure activity and exercise intensity and lower risk for atrial fibrillation. It was also found that patients with moderate...

  • MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese. Fu-Chih Hsiao; Yung-Hsin Yeh; Wei-Jan Chen; Yi-Hsin Chan; Chi-Tai Kuo; Chun-Li Wang; Chi-Jen Chang; Hsin-Yi Tsai; Feng-Chun Tsai; Lung-An Hsu // International Journal of Molecular Sciences;2016, Vol. 17 Issue 4, p521 

    Matrix metalloproteinase (MMP) plays an important role in the pathogenesis of atrial fibrillation (AF). The MMP9 promoter has a functional polymorphism rs3918242 that can regulate the level of gene transcription. This study recruited 200 AF patients and 240 controls. The MMP9 rs3918242 was...

  • Atrial Fibrillation in Hypertension: An Established Association with Several Unresolved Issues. Kolettis, Theofilos; Goudevenos, John; Korantzopoulos, Panagiotis // Cardiology;2003, Vol. 100 Issue 2, p105 

    Presents a letter to the editor about an association between atrial fibrillation and hypertension highlighting various unresolved issues.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics